The U.S. FDA has rejected Novartis’s bid to repurpose a drug now approved for rare inflammatory diseases to be used in a group of heart attack survivo
US doctors must realize that many cancer patients battle “financial toxicity” along with their disease, researchers say
Pfizer CEO Ian Read will hand over the reins of the largest U.S. drugmaker to veteran insider Albert Bourla in January...
Minority doctors in training routinely deal with bias, sometimes subtle, sometimes not so subtle, a new study suggests.
Pfizer Inc said that its once-daily oral drug to treat a rare form of lung cancer received approval from the U.S. FDA.